A novel anticancer effect of Astragalus saponins: Transcriptional activation of NSAID‐activated gene

Abstract

Astragalus membranaceus has been used to ameliorate the side effects of antineoplastic drugs because of its immunomodulating nature. We had recently demonstrated that total Astragalus saponins (AST) possess anticarcinogenic and proapoptotic properties in human colon cancer cells and tumor xenograft. In this study, we identified NSAID-activated gene (NAG-1) as a potential molecular target of AST. The growth-inhibitory and proapoptotic effects of AST were assessed in a panel of human cancer cell lines. Hoechst 33342 nuclear staining, Annexin V-FITC/propidium iodide staining, Western immunoblotting, real-time PCR, luciferase reporter assay and electrophoretic mobility shift assay were conducted to determine the association of NAG-1 and related transcription factors with AST during its regulation of apoptotic activities. Moreover, the combined proapoptotic and NAG-1 promoting activities of AST and/or inhibitors of the PI3K-Akt pathway were also examined. AST caused overexpression of NAG-1, leading to PARP cleavage and apoptosis. The induction of NAG-1 promoter activity by the drug was associated with increased gene expression, in addition to prior increase in Egr-1 expression and DNA binding activity. AST-induced NAG-1 activation was intensified when PI3K inhibitor LY294002 or Akt inhibitor was cotreated and reversed by NAG-1 siRNA transfection. Nevertheless, the extent of NAG-1 induction could not be altered by the ERK inhibitor PD98059. Our results indicate that NAG-1 is a potential molecular target of AST in its antitumorigenic and proapoptotic actions, which would have additive effects when used along with PI3K-Akt inhibitors. The information obtained could facilitate future development of a novel target-specific chemotherapeutic agent with known molecular pathway. ' 2009 UICC

Dracorhodin perchlorate induces the apoptosis of glioma cells

“…Anticancer agents derived from botanical herbs such as camptothecin and paclitaxel are the drugs of first choice in many tumor therapies, accounting for more than 30% of all anticancer drugs (9,10). Many scholars in China have come to believe that it is important to screen antitumor active ingredients from botanical herbs, particularly from traditional Chinese medicines.…”

Growth/differentiation factor-15: prostate cancer suppressor or promoter?

“…62 In addition, particular saponins induce GDF-15 in a PI3K-dependent manner. 63 Further evidence that GDF-15 has a role in cellular stress responses was presented in the work of Schlittenhardt et al, which showed enhanced expression of GDF-15 induced by oxidized low-density lipoproteins, TNFa, certain ceramides or hydrogen peroxide. This group also demonstrated the immunohistochemical colocalization of GDF-15 with PARP, caspase-3, manganese, super-oxide dismutase, cJun and p53 in native atherosclerotic tissue.…”

Characterization of novel astragaloside malonates from Radix Astragali by HPLC with ESI quadrupole TOF MS

“…[1], is one of the most widely used traditional Chinese medicine in China and other Oriental countries. It possesses various biological activities including immune-modulation [2,3], cardioprotective [4], anti-oxidative [5], anti-tumor [6] and antiinflammatory [7]. Chemical and biological investigations on Radix Astragali have revealed that triterpene saponins, flavonoids and polysaccharides are the main active components [2,6,8].…”